• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坦桑尼亚本土队列中非缺血性扩张型心肌病的特征:莫约研究

Characterization of Non-Ischemic Dilated Cardiomyopathy in a Native Tanzanian Cohort: MOYO Study.

作者信息

Fundikira Lulu Said, Chillo Pilly, Alimohamed Mohamed Z, Mayala Henry, Kifai Engerasiya, Aloyce Geofrey M, Kamuhabwa Appolinary, Kwesigabo Gideon, van Laake Linda W, Asselbergs Folkert W

机构信息

Muhimbili University of Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania, Tanzania.

Jakaya Kikwete Cardiac Institute, Dar es Salaam, Tanzania.

出版信息

Glob Heart. 2024 Feb 29;19(1):26. doi: 10.5334/gh.1298. eCollection 2024.

DOI:10.5334/gh.1298
PMID:38434152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10906337/
Abstract

BACKGROUND

Non-ischemic dilated cardiomyopathy (NIDCM) is a common cause of heart failure with progressive tendency. The disease occurs in one in every 2,500 individuals in the developed world, with high morbidity and mortality. However, detailed data on the role of NIDCM in heart failure in Tanzania is lacking.

AIM

To characterize NIDCM in a Tanzanian cohort with respect to demographics, clinical profile, imaging findings and management.

METHODS

Characterization of non-ischemic dilated cardioMyOpathY in a native Tanzanian cOhort (MOYO) is a prospective cohort study of NIDCM patients seen at the Jakaya Kikwete Cardiac Institute. Patients aged ≥18 years with a clinical diagnosis of heart failure, an ejection fraction of ≤45% on echocardiography and no evidence of ischemia were enrolled. Clinical data, echocardiography, electrocardiography (ECG), coronary angiography and stress ECG information were collected from February 2020 to March 2022.

RESULTS

Of 402 patients, n = 220 (54.7%) were males with a median (IQR) age of 55.0 (41.0, 66.0) years. Causes of NIDCM were presumably hypertensive n = 218 (54.2%), idiopathic n = 116 (28.9%), PPCM n = 45 (11.2%), alcoholic n = 10 (2.5%) and other causes n = 13 (3.2%). The most common presenting symptoms were dyspnea n = 342 (85.1%), with the majority of patients presenting with New York Heart Association (NYHA) Class III n = 195 (48.5%). The mean (SD) left ventricular ejection fraction (LVEF) was 29.4% (±7.7), and severe systolic dysfunction (LVEF <30%) was common n = 208 (51.7%). Compared with other forms of DCM, idiopathic DCM patients were significantly younger, had more advanced NYHA class (p < 0.001) and presented more often with left bundle branch block on ECG (p = 0.0042). There was suboptimal use of novel guidelines recommended medications ARNI n = 10 (2.5%) and SGLT2 2-inhibitors n = 2 (0.5%).

CONCLUSIONS

In our Tanzanian cohort, the majority of patients with NIDCM have an identified underlying cause, and they present at late stages of the disease. Patients with idiopathic DCM are younger with more severe disease compared to other forms of NIDCM.

摘要

背景

非缺血性扩张型心肌病(NIDCM)是心力衰竭的常见病因,具有进行性发展趋势。在发达国家,该病的发病率为每2500人中就有1人患病,其发病率和死亡率都很高。然而,关于NIDCM在坦桑尼亚心力衰竭中作用的详细数据尚缺乏。

目的

在一个坦桑尼亚队列中,从人口统计学、临床特征、影像学表现和治疗方面对NIDCM进行特征描述。

方法

在坦桑尼亚本土队列(MOYO)中对非缺血性扩张型心肌病进行特征描述,这是一项对在贾卡亚·基奎特心脏研究所就诊的NIDCM患者进行的前瞻性队列研究。纳入年龄≥18岁、临床诊断为心力衰竭、超声心动图显示射血分数≤45%且无缺血证据的患者。收集了2020年2月至2022年3月期间的临床数据、超声心动图、心电图(ECG)、冠状动脉造影和负荷心电图信息。

结果

在402例患者中,n = 220例(54.7%)为男性,中位(四分位间距)年龄为55.0(41.0,66.0)岁。NIDCM的病因据推测为高血压n = 218例(54.2%)、特发性n = 116例(28.9%)、围产期心肌病n = 45例(11.2%)、酒精性n = 10例(2.5%)和其他病因n = 13例(3.2%)。最常见的首发症状为呼吸困难n = 342例(85.1%),大多数患者表现为纽约心脏协会(NYHA)Ⅲ级n = 195例(48.5%)。平均(标准差)左心室射血分数(LVEF)为29.4%(±7.7),严重收缩功能障碍(LVEF <30%)很常见n = 208例(51.7%)。与其他形式的扩张型心肌病相比,特发性扩张型心肌病患者明显更年轻,NYHA分级更高(p < 0.001),心电图上更常出现左束支传导阻滞(p = 0.0042)。新型指南推荐药物ARNI的使用率较低n = 10例(2.5%),钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂的使用率为n = 2例(0.5%)。

结论

在我们的坦桑尼亚队列中,大多数NIDCM患者有明确的潜在病因,且疾病处于晚期。与其他形式的NIDCM相比,特发性扩张型心肌病患者更年轻,疾病更严重。

相似文献

1
Characterization of Non-Ischemic Dilated Cardiomyopathy in a Native Tanzanian Cohort: MOYO Study.坦桑尼亚本土队列中非缺血性扩张型心肌病的特征:莫约研究
Glob Heart. 2024 Feb 29;19(1):26. doi: 10.5334/gh.1298. eCollection 2024.
2
T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.T1 映射与非缺血性心肌病的转归:全因死亡率和心力衰竭。
JACC Cardiovasc Imaging. 2016 Jan;9(1):40-50. doi: 10.1016/j.jcmg.2015.12.001.
3
Combination of extracellular volume fraction by cardiac magnetic resonance imaging and QRS duration for the risk stratification for patients with non-ischemic dilated cardiomyopathy.利用心脏磁共振成像测定的细胞外容积分数与QRS波时限相结合对非缺血性扩张型心肌病患者进行危险分层
Heart Vessels. 2020 Oct;35(10):1439-1445. doi: 10.1007/s00380-020-01618-9. Epub 2020 May 16.
4
Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.比较非缺血性扩张型心肌病心力衰竭结局的 CMR 映射方法和心肌模式。
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1659-1669. doi: 10.1016/j.jcmg.2018.08.021. Epub 2018 Nov 15.
5
Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy.肥厚型心肌病扩张期与扩张型心肌病的临床特征比较。
Clin Cardiol. 2010 Jul;33(7):E24-8. doi: 10.1002/clc.20533.
6
Clinical and functional determinants of coronary flow reserve in non-ischemic dilated cardiomyopathy: an echocardiographic study.非缺血性扩张型心肌病中冠状动脉血流储备的临床和功能决定因素:一项超声心动图研究
Int J Cardiol. 2005 Oct 20;105(1):46-52. doi: 10.1016/j.ijcard.2004.11.013.
7
Natural History of Dilated Cardiomyopathy in Children.儿童扩张型心肌病的自然病史
J Am Heart Assoc. 2016 Jun 30;5(7):e003450. doi: 10.1161/JAHA.116.003450.
8
Comparison of Clinical Course and Outcomes between Dilated and Hypokinetic Non-Dilated Cardiomyopathy.扩张型和非扩张性低动力型心肌病的临床过程和结局比较。
Cardiology. 2023;148(5):395-401. doi: 10.1159/000531534. Epub 2023 Jun 13.
9
Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy.非缺血性扩张型心肌病左心室逆向重构的临床决定因素及预后
J Cardiovasc Dev Dis. 2022 Jan 11;9(1):20. doi: 10.3390/jcdd9010020.
10
Feasibility and limitations of mitral valve repair, with or without left ventricular reconstruction in non-ischemic dilated cardiomyopathy.在非缺血性扩张型心肌病中二尖瓣修复(无论是否联合左心室重建)的可行性及局限性
J Cardiol. 2018 Apr;71(4):329-335. doi: 10.1016/j.jjcc.2017.09.013. Epub 2017 Nov 7.

本文引用的文献

1
Yield of family screening in dilated cardiomyopathy within low-income setting: Tanzanian experience.
Cardiovasc J Afr. 2023 Jul 25;34:1-6. doi: 10.5830/CVJA-2023-037.
2
Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward.21世纪非洲的心血管疾病:未来的差距与优先事项
Front Cardiovasc Med. 2022 Nov 10;9:1008335. doi: 10.3389/fcvm.2022.1008335. eCollection 2022.
3
Association of Whole-Heart Myocardial Mechanics by Transthoracic Echocardiography with Presence of Late Gadolinium Enhancement by CMR in Non-Ischemic Dilated Cardiomyopathy.经胸超声心动图测量的全心心肌力学与心脏磁共振成像检测的非缺血性扩张型心肌病晚期钆增强的相关性
J Clin Med. 2022 Nov 8;11(22):6607. doi: 10.3390/jcm11226607.
4
Risk Factors and Prevalence of Dilated Cardiomyopathy in Sub-Saharan Africa: A Systematic Review.撒哈拉以南非洲扩张型心肌病的危险因素和患病率:系统评价。
Glob Heart. 2022 Oct 21;17(1):76. doi: 10.5334/gh.1166. eCollection 2022.
5
Impact of type 2 diabetes mellitus on left ventricular deformation in non-ischemic dilated cardiomyopathy patients assessed by cardiac magnetic resonance imaging.心脏磁共振成像评估 2 型糖尿病对非缺血性扩张型心肌病患者左心室变形的影响。
Cardiovasc Diabetol. 2022 Jun 4;21(1):94. doi: 10.1186/s12933-022-01533-5.
6
Development and validation of a nomogram to predict the risk of death within 1 year in patients with non-ischemic dilated cardiomyopathy: a retrospective cohort study.建立并验证预测非缺血性扩张型心肌病患者 1 年内死亡风险的列线图:一项回顾性队列研究。
Sci Rep. 2022 May 20;12(1):8513. doi: 10.1038/s41598-022-12249-7.
7
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
8
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry.家族性与散发性扩张型心肌病的差异:欧洲心脏病学会(ESC)心脏疾病与心肌炎注册研究(EORP)
ESC Heart Fail. 2021 Feb;8(1):95-105. doi: 10.1002/ehf2.13100. Epub 2020 Nov 11.
9
Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy.肥胖相关的心室重塑在扩张型和肥厚型心肌病中会加剧。
Cardiovasc Diagn Ther. 2020 Jun;10(3):559-567. doi: 10.21037/cdt-19-587.
10
Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective.撒哈拉以南非洲地区与高收入国家心血管疾病的比较:流行病学视角。
Glob Heart. 2020 Feb 12;15(1):15. doi: 10.5334/gh.403.